Prexton Therapeutics
CHWho owns Prexton Therapeutics?
Prexton Therapeutics was owned by Ysios Capital Partners through Ysios BioFund II Innvierte (2016 vintage) from 2017 to 2018, exited via Trade Sale. Across its history, Prexton Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-08-03
Key facts
- ·Fully exited in 2018.
- ·Average hold across 2 realized cycles: 2 years.
Ownership history
2 ownership periods · co-invest detected
More from Ysios BioFund II Innvierte
Other portfolio companies in the same fund.
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Prexton Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Prexton Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in